Rhinoconjunctivitis

• CLINICAL_TRIALS trial_result · 2013-02-11
  Clinical Trial Update: Multicenter Trial of Immunotherapy With House Dust Mite Allergoid [Phase 3]

  A multicenter Phase 3 trial evaluating immunotherapy with House Dust Mite Allergoid for rhinoconjunctivitis has completed.

• CLINICAL_TRIALS trial_result · 2012-05-24
  Clinical Trial Update: An Optional Two Year Follow Up Study to Study CP005A

  Two-year follow-up study to CP005A by Circassia has completed, investigating cat allergy and rhinoconjunctivitis.

• CLINICAL_TRIALS trial_result · 2011-05-20
  Clinical Trial Update: Cat-PAD Follow on Study

  The Cat-PAD follow-on clinical trial has completed, sponsored by Circassia Limited. The update does not provide results.

• CLINICAL_TRIALS trial_result · 2010-12-17
  Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) [Phase 3]

  Phase 3 trial of depigmented and polymerized Olea europaea allergen extract (GPIT) for allergic rhinoconjunctivitis has completed.

• CLINICAL_TRIALS trial_result · 2007-04-06
  Clinical Trial Update: Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration [Phase 1]

  Phase 1 clinical trial assessing the clinical efficacy and safety of a novel epicutaneous allergen immunotherapy for grass pollen–induced rh…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.